Attachment C 60-DayFRN 0920-0004

72435

Federal Register / Vol. 70, No. 232 / Monday, December 5, 2005 / Notices

manner. At the onset of this surveillance
program in 1968, the CSTE and CDC
decided on which diseases warranted
surveillance. These diseases are
reviewed and revised based on
variations in the public’s health.
Surveillance forms are distributed to the
State and local health departments who
voluntarily submit these reports to CDC
at variable frequencies, either weekly or
monthly. CDC then calculates and
publishes weekly statistics via the
Morbidity and Mortality Weekly Report
(MMWR), providing the states with
timely aggregates of their submissions.
The following diseases/conditions are
included in this program: Diarrheal
disease surveillance (includes
campylobacter, salmonella, and
shigella), foodborne outbreaks, arboviral
surveillance (ArboNet), Influenza virus,
including the annual survey and
influenza-like illness, Respiratory and
Enterovirus surveillance, rabies,
waterborne diseases, cholera and other
vibrio illnesses, and calicinet. These
data are essential on the local, state, and
Federal levels for measuring trends in
diseases, evaluating the effectiveness of
current prevention strategies, and
determining the need for modifying
current prevention measures.
This request is for reinstatement of
the data collection for three years.
Because of the distinct nature of each of
the diseases, the number of cases
reported annually is different for each.
There is no cost to respondents other
than their time.

on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–06–0004]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4766 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information

Proposed Project
National Disease Surveillance
Program—II. Disease Summaries (0920–
0004)—Reinstatement—National Center
for Infectious Diseases (NCID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Surveillance of the incidence and
distribution of disease has been an
important function of the U.S. Public
Health Service (PHS) since 1878.
Through the years, PHS/CDC has
formulated practical methods of disease
control through field investigations. The
CDC National Disease Surveillance
Program is based on the premise that
diseases cannot be diagnosed,
prevented, or controlled until existing
knowledge is expanded and new ideas
developed and implemented. Over the
years, the mandate of CDC has
broadened to include preventive health
activities and the surveillance systems
maintained have expanded.
CDC and the Council of State and
Territorial Epidemiologists (CSTE)
collect data on disease and preventable
conditions in accordance with jointly
approved plans. Changes in the
surveillance program and in reporting
methods are effected in the same

ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents

Form
Diarrheal Disease Surveillance:
—Campylobacter (electronic) ..........................................................................
—Salmonella (electronic) .................................................................................
—Shigella (electronic) ......................................................................................
Foodborne Outbreak Form ..............................................................................
Arboviral Surveillance (ArboNet) .....................................................................
Influenza:
—Influenza virus (fax, Oct–May) .....................................................................
—Influenza virus (fax, year round) ..................................................................
—Influenza virus (electronic, Oct–May) ...........................................................
—Influenza virus (electronic, year round) ........................................................
Influenza Annual Survey ..................................................................................
Influenza-like Illness (Oct–May) .......................................................................
Influenza-like Illness (year round) ....................................................................
Monthly Respiratory & Enterovirus Surveillance Report:
—Excel format (electronic) ..............................................................................
—Access format (electronic) ............................................................................
National Respiratory & Enteric Virus Surveillance System (NREVSS) ...........
Rabies (electronic) ...........................................................................................
Rabies (paper) .................................................................................................
Waterborne Diseases Outbreak Form .............................................................
Cholera and other Vibrio illnesses ..................................................................
CaliciNet ...........................................................................................................
Total ......................................................................................................

VerDate Aug<31>2005

17:14 Dec 02, 2005

Jkt 208001

PO 00000

Frm 00014

Fmt 4703

Number of
responses

Hours/
response

Response
burden

53
53
53
52
54

52
52
52
25
717

3/60
3/60
3/60
15/60
5/60

138
138
138
325
3,227

44
12
14
10
80
620
130

33
52
33
52
1
33
52

10/60
10/60
5/60
5/60
15/60
15/60
15/60

242
104
39
43
20
5115
1690

25
2
89
40
15
60
300
30

12
12
52
12
12
2
1
10

15/60
15/60
10/60
8/60
20/60
20/60
20/60
10/60

75
6
771
64
60
40
100
50

........................

........................

........................

12,257

Sfmt 4703

E:\FR\FM\05DEN1.SGM

05DEN1

72436

Federal Register / Vol. 70, No. 232 / Monday, December 5, 2005 / Notices

Dated: November 29, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E5–6811 Filed 12–2–05; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Board of Scientific Counselors,
National Center for Infectious Diseases
(NCID).
Times and Dates: 1 p.m.–5:30 p.m.,
November 29, 2005. 8:30 a.m.–5 p.m.,
November 30, 2005.
Place: CDC, Building 19, 1600 Clifton
Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Board of Scientific
Counselors, NCID, provides advice and
guidance to the Director, CDC, and Director,
NCID, in the following areas: Program goals
and objectives; strategies; program
organization and resources for infectious
disease prevention and control; and program
priorities.
Matters to Be Discussed: Agenda items will
include:
1. Opening Session: NCID Update.
2. CCID Update.
3. Environmental Microbiology.
4. Development of CDC Research Agenda.
5. Veterinary-Human Public Health Interface.
6. Global Disease Detection Initiative.
7. Topic Updates.
a. Chronic Wasting Disease.
b. Quarantine Update.
Other agenda items include
announcements/introductions; follow-up on
actions recommended by the Board May
2005; consideration of future directions,
goals, and recommendations.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and should
be received by the contact person listed
below prior to the opening of the meeting.
The Federal Register notice is being
published less than fifteen days before the
date of the meeting.
Contact Person for More Information: Tony
Johnson, Office of the Director, NCID, CDC,
Mailstop E–51, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, e-mail
[email protected]; telephone 404/498–3249.
The Director, Management Analysis and
Services office has been delegated the
authority to sign Federal Register notices

17:14 Dec 02, 2005

Jkt 208001

Dated: November 29, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–23599 Filed 11–30–05; 9:56 am]
BILLING CODE 4163–18–P

Board of Scientific Counselors,
National Center for Infectious
Diseases: Meeting

VerDate Aug<31>2005

pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.

Centers for Disease Control and
Prevention
The National Institute for Occupational
Safety and Health (NIOSH)
Name: Continued Discussions of
Concepts for Standards for Approval of
Respirators for Use against Chemical,
Biological, Radiological and Nuclear
Agents (CBRN) and Concepts for
Standards for Industrial, Powered Air
Purifying Respirator (PAPR).
Date and Time: December 13, 2005, 9
a.m.–4 p.m.
The meeting will address concepts for
standards for CBRN Closed Circuit, SelfContained Breathing Apparatus (SCBA),
CBRN PAPR, and Industrial PAPR.
Place: Sheraton Station Square Hotel,
300 W. Station Square Drive, Pittsburgh,
Pennsylvania 15219–1162.
Purpose: NIOSH will continue
discussions of concepts for standards
and testing processes for PAPR and
Closed Circuit, SCBA suitable for
respiratory protection against CBRN
agents. NIOSH will also continue
conceptual discussions for establishing
Industrial PAPR requirements. NIOSH,
along with the United States Army
Research, Development and Engineering
Command (RDECOM) and the National
Institute for Standards and Technology
(NIST), will present information to
attendees concerning the concept
development for the CBRN PAPR
standard and the CBRN Closed Circuit,
SCBA standard. Participants will be
given an opportunity to ask questions
on these topics and to present
individual comments for consideration.
Interested participants may obtain a
copy of the CBRN PAPR, the Industrial
PAPR concept paper, the CBRN Closed
Circuit and SCBA concept paper, as
well as earlier versions of other concept
papers used during the standard
development effort, from the NIOSH
National Personnel Protective
Technology Laboratory (NPPTL) Web
site, address: http://www.cdc.gov/niosh/
npptl. The November 4, 2005 concept

PO 00000

Frm 00015

Fmt 4703

Sfmt 4703

paper will be used as the basis for
discussion at the public meeting.
Municipal, state, and Federal responder
groups, particularly in locations
considered potential terrorism targets,
have been developing and modifying
response and consequence management
plans for domestic security and
preparedness issues. Since the World
Trade Center and anthrax incidents,
most emergency response agencies have
operated with a heightened appreciation
of the potential scope and sustained
resource requirements for coping with
such events. The Federal Interagency
Board for Equipment Standardization
and Interoperability (IAB) has worked to
identify personal protective equipment
that is already available on the market
for responders’ use. The IAB has
identified the development of standards
or guidelines for respiratory protection
equipment as a top priority. NIOSH,
NIST, the National Fire Protection
Association (NFPA), and the
Occupational Safety and Health
Administration have entered into a
Memorandum of Understanding
defining each agency or organization’s
role in developing, establishing, and
enforcing standards or guidelines for
responders’ respiratory protective
devices. NIST has initiated Interagency
Agreements with NIOSH and RDECOM
to aid in the development of appropriate
protection standards or guidelines.
NIOSH has the lead in developing
standards or guidelines to test, evaluate,
and approve respirators. NIOSH,
RDECOM, and NIST hosted public
meetings on April 17 and 18, 2001; June
18 and 19, 2002; October 16 and 17,
2002; April 29, 2003; June 25, 2003;
October 16, 2003; May 4, 2004;
December 15, 2004; and July 19 and 20,
2005; presenting their progress in
assessing respiratory protection needs of
responders to CBRN incidents. The
methods or models for developing
hazard and exposure estimates, and the
status in evaluating test methods and
performance standards that may be
applicable as future CBRN respirator
standards or guidelines were discussed
at these meetings. Three NIOSH CBRN
respirator standards and several NFPA
standards for ensembles, SCBA, and
protective clothing were the first
adopted by the U.S. Department of
Homeland Security (DHS). On February
26, 2004, DHS adopted, as DHS
standards, three NIOSH criteria for
testing and certifying respirators for
protection against CBRN exposures.
NIOSH uses the criteria to test (1) SCBA
for use by emergency responders against
CBRN, (2) PAPR for use by emergency
responders against CBRN exposures,

E:\FR\FM\05DEN1.SGM

05DEN1